Synergistic Anti-Obesity Effects of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum (CKDB-322) in High-Fat-Diet-Induced Obese Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167991 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hye-Ji Noh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Probiotics Research Laboratory, Chong Kun Dang Bio (CKDBio) Research Institute, Ansan 15604, Republic of Korea. Hauptthemen laut MEDLINE: Obesity, Diatoms, Anti-Obesity Agents, Probiotics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry & Energy (MOTIE, Korea), Ministry of Trade, Industry & Energy (MOTIE, Republic of Korea).
Abstract (Originalsprache)
Obesity and associated metabolic disorders are rising globally, necessitating effective dietary strategies. CKDB-322, a formulation containing Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum, was evaluated for anti-obesity efficacy using in vitro adipocyte differentiation and in vivo high-fat-diet (HFD)-induced obese mouse models. In 3T3-L1 cells, CKDB-322 suppressed adipogenesis by downregulating PPARγ and C/EBPα and enhancing glycerol release. In mice, 8 weeks of oral administration—particularly at the CKDB-322-M dose—significantly reduced body weight gain, adiposity, and serum glucose, triglyceride, and cholesterol levels without affecting liver function. Gene expression analysis revealed the strong inhibition of lipogenic markers (SREBP-1c, ACC, and FAS) in addition to activation of the fatty acid oxidation (CPT-1α and PPARα) and energy metabolism (PGC-1α and AMPK) pathways, with the most pronounced effects in the CKDB-322-M group, which also exhibited the greatest reduction in leptin. These molecular effects were confirmed histologically by decreased adipocyte hypertrophy and ameliorated hepatic steatosis. Collectively, these findings demonstrate that CKDB-322 exerts lipid-modulatory effects through multiple pathways, supporting its potential as a novel functional dietary ingredient for obesity and metabolic disorder prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Probiotics Research Laboratory, Chong Kun Dang Bio (CKDBio) Research Institute, Ansan 15604, Republic of Korea.
- Microalgae Ask Us Co., Ltd., Gangneung 25441, Republic of Korea.
- Department of Biology Education, College of Education, Chungbuk National University, Cheongju 28644, Republic of Korea.
ORCID-Profile: Chang Hun Shin
Förderung
- Ministry of Trade, Industry & Energy (MOTIE, Korea)
- Ministry of Trade, Industry & Energy (MOTIE, Republic of Korea)
Zitieren
APA
Noh, H. J., Eom, J. I., Park, S. J., Shin, C. H., Kim, S. M., Pan, C. H., & Lee, J. K. (2025). Synergistic Anti-Obesity Effects of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum (CKDB-322) in High-Fat-Diet-Induced Obese Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167991
Vancouver
Noh HJ, Eom JI, Park SJ, Shin CH, Kim SM, Pan CH, et al. Synergistic Anti-Obesity Effects of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum (CKDB-322) in High-Fat-Diet-Induced Obese Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167991
BibTeX
@article{Noh2025,
author = {Noh, Hye-Ji and Eom, Jae-In and Park, Soo-Je and Shin, Chang Hun and Kim, Se-Min and Pan, Cheol-Ho and Lee, Jae Kwon},
title = {Synergistic Anti-Obesity Effects of Lactiplantibacillus plantarum Q180 and Phaeodactylum tricornutum (CKDB-322) in High-Fat-Diet-Induced Obese Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167991}
}
EUVIMED